Early NLR Changes Predict mRCC Immunotherapy Outcomes – Renal and Urology News
Renal and Urology News |
Early NLR Changes Predict mRCC Immunotherapy Outcomes
Renal and Urology News Rises and decreases in neutrophil-to-lymphocyte ratio at 6 weeks after treatment with anti-PD-1/PD-L1 immune checkpoint blockade is associated with progression-free and overall survival. Changes in neutrophil-to-lymphocyte ratio (NLR) in response to … |
